Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023 07:05 ET
|
Celcuity Inc.
Received FDA clearance of IND to evaluate gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer (mCRPC) Entered into a...
Gravity Reports Third Quarter of 2023 Results and Business Updates
November 13, 2023 06:10 ET
|
GRAVITY Co., Ltd.
Seoul, Korea, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Seoul, South Korea – November 13, 2023 – GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile...
Bigbank's Financial Results for October 2023
November 10, 2023 09:30 ET
|
BIGBANK AS
October 2023 results were good for Bigbank. Both the deposit portfolio and the loan portfolio grew. In deposits, growth came from the savings deposit portfolio, the volume of which exceeded the...
Bigbank AS 2023. aasta oktoobri tulemused
November 10, 2023 09:30 ET
|
BIGBANK AS
2023. aasta oktoobri tulemused olid Bigbanki jaoks head. Kasvasid nii hoiuseportfell kui ka laenuportfell. Hoiustes tuli kasv säästuhoiuse portfellist, mille maht ületas oktoobris 900 milljoni euro...
Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook
November 10, 2023 08:05 ET
|
Palisade Bio, Inc.
– Transformational transaction jumpstarts development pipeline into high-value inflammatory bowel disease (IBD) market – Lead program, PALI-2108, oral prodrug therapy for the treatment...
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023 16:15 ET
|
CytoSorbents
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023 16:01 ET
|
Harpoon Therapeutics Inc.
October 2023 financing funds late-stage clinical trials of HPN328 in multiple tumor types Positive interim results from Phase 1/2 trial of T cell engager HPN328 in patients with small cell lung...
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
November 09, 2023 08:00 ET
|
ProPhase Labs, Inc.
Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024...
Aemetis Reports Third Quarter 2023 Financial Results
November 09, 2023 08:00 ET
|
Aemetis, Inc.
Reports Net Income of $30.7 million and Basic EPS of $0.79 CUPERTINO, CA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and...
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023 07:00 ET
|
Synlogic, Inc.
- Underwritten public offering of $21.0 million and earned $2.5 million milestone payment from Roche have extended cash runway into the first half of 2025 - - Progress of the Synpheny-3 pivotal trial...